Eva Fortea Verdejo Score: 30
Analyst at
Wells Fargo
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+33.1%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
64%
7 W / 4 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
33%
3 W / 6 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
11%
1 W / 8 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
11%
1 W / 8 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
63%
5 W / 3 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
70%
7 W / 3 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 09, 2026 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$124.00
Est. +1%
|
$122.88 | $123.80 |
Bullseye Hit (±1%)
|
$123.73
+0.7%
|
| Jun 03, 2026 |
Celcuity Inc
CELC
|
BUY |
$166.00
Est. +82%
|
$91.42 | $108.32 |
Pending
|
$107.95
+18.1%
|
| Feb 26, 2026 |
Revolution Medicines Inc
RVMD
|
BUY |
$144.00
Est. +39%
|
$103.24 | $193.10 |
Target Met
|
$189.24
+83.3%
|
| Oct 31, 2025 |
Immunocore Holdings plc - ADR
IMCR
|
BUY |
$60.00
Est. +86%
|
$32.19 | $40.71 |
Pending
|
$32.50
+1.0%
|
| May 28, 2025 |
ITeos Therapeutics Inc
ITOS
|
BUY |
$12.00
Est. +19%
|
$10.06 | $11.34 |
Miss
|
$10.15
+0.9%
|
| May 23, 2025 |
Bicara Therapeutics Inc. Common Stock
BCAX
|
SELL |
$8.00
Est. +14%
|
$9.27 | $8.51 (Low) |
Miss
|
$29.00
-212.8%
|
| May 14, 2025 |
ITeos Therapeutics Inc
ITOS
|
BUY |
$13.00
Est. +88%
|
$6.92 | $11.34 |
Miss
|
$10.15
+46.7%
|
| May 07, 2025 |
Arcus Biosciences Inc
RCUS
|
BUY |
$26.00
Est. +220%
|
$8.12 | $28.72 |
Target Met
|
$30.33
+273.5%
|
| Oct 08, 2024 |
Arcus Biosciences Inc
RCUS
|
BUY |
$29.00
Est. +60%
|
$18.08 | $18.98 |
Miss
|
$30.33
+67.8%
|
| Aug 13, 2024 |
ITeos Therapeutics Inc
ITOS
|
BUY |
$31.00
Est. +114%
|
$14.50 | $18.12 |
Miss
|
$10.15
-30.0%
|
| May 03, 2024 |
Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A
KNSA
|
BUY |
$34.00
Est. +75%
|
$19.38 | $28.15 |
Miss
|
$64.53
+233.0%
|
Nuvalent Inc - Ordinary Shares - Class A
NUVL
Jun 09, 2026
Signal & Target
BUY
$124.00
Start Price
$122.88
Best Price (1Y)
$123.80
Current Price
$123.73
Return
+0.7%
Celcuity Inc
CELC
Jun 03, 2026
Signal & Target
BUY
$166.00
Start Price
$91.42
Best Price (1Y)
$108.32
Current Price
$107.95
Return
+18.1%
Revolution Medicines Inc
RVMD
Feb 26, 2026
Signal & Target
BUY
$144.00
Start Price
$103.24
Best Price (1Y)
$193.10
Current Price
$189.24
Return
+83.3%
Immunocore Holdings plc - ADR
IMCR
Oct 31, 2025
Signal & Target
BUY
$60.00
Start Price
$32.19
Best Price (1Y)
$40.71
Current Price
$32.50
Return
+1.0%
ITeos Therapeutics Inc
ITOS
May 28, 2025
Signal & Target
BUY
$12.00
Start Price
$10.06
Best Price (1Y)
$11.34
Current Price
$10.15
Return
+0.9%
Bicara Therapeutics Inc. Common Stock
BCAX
May 23, 2025
Signal & Target
SELL
$8.00
Start Price
$9.27
Best Price (1Y)
$8.51
Current Price
$29.00
Return
-212.8%
ITeos Therapeutics Inc
ITOS
May 14, 2025
Signal & Target
BUY
$13.00
Start Price
$6.92
Best Price (1Y)
$11.34
Current Price
$10.15
Return
+46.7%
Arcus Biosciences Inc
RCUS
May 07, 2025
Signal & Target
BUY
$26.00
Start Price
$8.12
Best Price (1Y)
$28.72
Current Price
$30.33
Return
+273.5%
Arcus Biosciences Inc
RCUS
Oct 08, 2024
Signal & Target
BUY
$29.00
Start Price
$18.08
Best Price (1Y)
$18.98
Current Price
$30.33
Return
+67.8%
ITeos Therapeutics Inc
ITOS
Aug 13, 2024
Signal & Target
BUY
$31.00
Start Price
$14.50
Best Price (1Y)
$18.12
Current Price
$10.15
Return
-30.0%
Signal & Target
BUY
$34.00
Start Price
$19.38
Best Price (1Y)
$28.15
Current Price
$64.53
Return
+233.0%